Cite Filings / ABCL / 0001564590-21-059298

Feed Companies Filings Check

Sign in

8-K

Current Report

AbCellera Biologics Inc. Filed 2021-12-03 Acc 0001564590-21-059298

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , abcl-8k_20211202.htm

Around this filing

2021-12-07 424B3 Prospectus
2021-12-07 8-K Executive or director change
2021-12-07 4 Director bought 86,938 shares at $14.02 ($1,218,871)
2021-12-03 8-K Regulation FD disclosure
2021-12-03 4/A Chief Operating Officer acquired 83,333 shares (option exercise)
2021-12-02 4 Chief Operating Officer acquired 83,333 shares (option exercise)
2021-11-09 8-K Results of operations · Regulation FD disclosure

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading abcl-8k_20211202.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…